Elena S. Ratner, MD
Assistant Professor
Yale University School of Medicine
15 Barberry Ln
New Haven,
CT
USA
06525
Papers:
14 - Focused Plenary
Sexual function among older female cancer survivors
167 - Poster Session A
Weekly ixabepilone with or without concurrent bevacizumab in the treatment of platinum/taxane-resistant endometrial and ovarian cancers: an institutional experience
211 - Poster Session A
MK-2206 sensitizes BRCA2 mutant ovarian adenocarcinoma to cisplatin and poly ADP (adenosine diphosphate)-ribose polymerase (PARP) inhibitor therapy
241 - Poster Session A
Solitomab, an EpCAM/CD3 bispecific antibody (BiTE®), is highly active against primary chemotherapy-resistant ovarian cancer cell lines in vitro and fresh tumor cells ex vivo